Zacks Research Issues Pessimistic Outlook for BDMD Earnings

Baird Medical Investment Holdings Limited (NASDAQ:BDMD) – Equities researchers at Zacks Research lowered their FY2026 EPS estimates for Baird Medical Investment in a report issued on Thursday, September 10th. Zacks Research analyst T. Kerr now expects that the company will post earnings of $0.08 per share for the year, down from their prior estimate of $0.10. The consensus estimate for Baird Medical Investment’s current full-year earnings is $0.10 per share.

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Baird Medical Investment in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Baird Medical Investment Price Performance

Shares of NASDAQ:BDMD opened at $1.06 on Wednesday. Baird Medical Investment has a 12 month low of $0.76 and a 12 month high of $3.70. The company has a 50-day moving average price of $1.11 and a 200-day moving average price of $1.52.

Hedge Funds Weigh In On Baird Medical Investment

A hedge fund recently bought a new position in Baird Medical Investment stock. Citadel Advisors LLC bought a new position in Baird Medical Investment Holdings Limited (NASDAQ:BDMD) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 54,895 shares of the company’s stock, valued at approximately $63,000. Citadel Advisors LLC owned approximately 0.13% of Baird Medical Investment as of its most recent filing with the Securities and Exchange Commission (SEC). 19.78% of the stock is owned by institutional investors.

Baird Medical Investment Company Profile

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.